Prognostic role of multiple abnormal genes in non-small-cell lung cancer

doi:10.12998/wjcc.v10.i22.7772

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5872)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series, Tables (1-1) series.

Item

Count

PDF

221

WORD

HTML

2478

Figures (1-9)

634

Tables (1-1)

583

Sum=3967

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

453

Download

1466

Sum=1919

Aug 6, 2022 (publication date) through Nov 28, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Clin Cases. Aug 6, 2022; 10(22): 7772-7784
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7772

Table 1 Variables between patients who received chemotherapy or TKI therapy

Therapy type	Chemotherapy	TKI therapy	P value
Sex
Female	7 (8.2)	20 (23.5)	0.0021
Male	37 (43.5)	21 (23.7)
Age
Less than 50 yr	7 (8.2)	4 (4.7)	0.7334
50-70 yr	27 (31.8)	26 (30.6)
Greater than 70 yr	10 (11.8)	11 (12.9)
Smoking history
Ever	27 (31.7)	15 (17.6)	0.0302
Never	17 (20.0)	26 (30.6)
Tumor histology
LUAD	35 (41.1)	37 (43.5)	0.2317
LUSC & Others	9 (10.6)	4 (4.7)
Cancer stage
I and II	2 (2.4)	4 (4.7)	0.4227
III and IV	42 (49.4)	37 (43.5)
OS
< 12 mo	28 (32.9)	12 (14.1)	0.0022
≥ 12 mo	16 (18.8)	29 (34.1)

TKI: Tyrosine kinase inhibitor; LUAD: Lung adenocarcinoma; OS: Overall survival.

Full Size Table

Citation: Yan LD, Yang L, Li N, Wang M, Zhang YH, Zhou W, Yu ZQ, Peng XC, Cai J. Prognostic role of multiple abnormal genes in non-small-cell lung cancer. World J Clin Cases 2022; 10(22): 7772-7784
URL: https://www.wjgnet.com/2307-8960/full/v10/i22/7772.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i22.7772